Consensus guidelines recommend dopamine agonists (DAs) as the mainstay treatment for
prolactinomas. In most patients, DAs achieve tumor shrinkage and normoprolactinemia at …

Simple Summary This review updates recent advances in the pathogenesis, diagnosis, and
therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine …

Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

Aggressive prolactinoma (APRL) is a subgroup of aggressive pituitary tumors (accounting
for 10% of all hypophyseal neoplasia) which are defined by: invasion based on radiological …

Methods: This GL has been developed following the methods described in the Manual of the
Italian National Guideline System. For each question, the panel appointed by Associazione …

Among pituitary adenomas, prolactinomas are the most frequently diagnosed (about 50%).
Dopamine agonists are generally effective in the treatment of prolactinomas. However, a …

Growth-hormone (GH)-and prolactin (PRL)-secreting PitNETs (pituitary neuroendocrine
tumors) are divided into multiple histological subtypes, which determine their clinical and …

微生物-肠-脑轴(microbiota-gut-brain axis, MGBA) 是由神经, 内分泌和免疫系统相互作用而
构成的复杂网络, 为揭示肠道菌群如何影响脑恶性肿瘤的生物学特性提供了关键的理论框架 …

Hyperprolactinemia is the most common endocrine disorder of the hypothalamic-pituitary
axis. Prolactin is synthesized by the anterior pituitary lactotroph cells and is regulated by …